Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Santen Pharmaceutical Co Ltd (SNPHF)
OTHER OTC:SNPHF
Santen Pharmaceutical Co (SNPHF) Stock Price & Analysis
5 Followers
SNPHF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.81 - $10.84
Previous Close$9.97
Volume1.00
Average Volume (3M)1.14K
Market Cap
$3.74B
Enterprise Value$3.32B
Total Cash (Recent Filing)¥62.32B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)18.3
Beta0.39
Next Earnings
May 09, 2024EPS EstimateN/A
Last Dividend Ex-Date
Mar 29, 2016Dividend Yield2.36%
Share Statistics
EPS (TTM)0.54
Shares Outstanding375,992,354
10 Day Avg. Volume33
30 Day Avg. Volume1,136
Standard Deviation0.08
R-Squared0.03
Alpha-0.00483
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
SNPHF FAQ
What was Santen Pharmaceutical Co Ltd’s price range in the past 12 months?
Santen Pharmaceutical Co Ltd lowest stock price was $7.81 and its highest was $10.84 in the past 12 months.
What is Santen Pharmaceutical Co Ltd’s market cap?
Currently, no data Available
When is Santen Pharmaceutical Co Ltd’s upcoming earnings report date?
Santen Pharmaceutical Co Ltd’s upcoming earnings report date is May 09, 2024 which is tomorrow.
How were Santen Pharmaceutical Co Ltd’s earnings last quarter?
Santen Pharmaceutical Co Ltd released its earnings results on Feb 08, 2024. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of N/A by $0.14.
Is Santen Pharmaceutical Co Ltd overvalued?
According to Wall Street analysts Santen Pharmaceutical Co Ltd’s price is currently Overvalued.
Does Santen Pharmaceutical Co Ltd pay dividends?
Santen Pharmaceutical Co Ltd pays a Semiannually dividend of $0.11 which represents an annual dividend yield of 2.36%. See more information on Santen Pharmaceutical Co Ltd dividends here
What is Santen Pharmaceutical Co Ltd’s EPS estimate?
Santen Pharmaceutical Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Santen Pharmaceutical Co Ltd have?
Santen Pharmaceutical Co Ltd has 375,992,340 shares outstanding.
What happened to Santen Pharmaceutical Co Ltd’s price movement after its last earnings report?
Santen Pharmaceutical Co Ltd reported an EPS of $0.14 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.55%.
Which hedge fund is a major shareholder of Santen Pharmaceutical Co Ltd?
Currently, no hedge funds are holding shares in SNPHF
---
Santen Pharmaceutical Co Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.40%
12-Months-Change
Fundamentals
Return on Equity
8.86%
Trailing 12-Months
Asset Growth
-4.70%
Trailing 12-Months
Company Description
Santen Pharmaceutical Co Ltd
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the Pharmaceuticals and Other segments. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Other segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.
---
Technical Analysis
---